Dian-xu Feng

550 total citations
20 papers, 432 citations indexed

About

Dian-xu Feng is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Dian-xu Feng has authored 20 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Dian-xu Feng's work include Pancreatitis Pathology and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Lipid metabolism and disorders (3 papers). Dian-xu Feng is often cited by papers focused on Pancreatitis Pathology and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Lipid metabolism and disorders (3 papers). Dian-xu Feng collaborates with scholars based in China, Canada and Puerto Rico. Dian-xu Feng's co-authors include Hongchang Li, Yafeng Chen, Ke Xu, Yiming Jiang, Teng Chen, Han Cai, Yi Mei, Wenjie Sun, Feng Wen and Guifang Sun and has published in prestigious journals such as Gene, Medicine and Frontiers in Pharmacology.

In The Last Decade

Dian-xu Feng

19 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dian-xu Feng China 13 222 125 105 103 45 20 432
Hongyan Chen China 10 165 0.7× 69 0.6× 101 1.0× 84 0.8× 48 1.1× 22 364
Xinjuan Kong China 11 304 1.4× 159 1.3× 98 0.9× 96 0.9× 41 0.9× 34 521
Ya-Jun Yang China 12 371 1.7× 129 1.0× 70 0.7× 55 0.5× 51 1.1× 16 564
Xinye Wang China 13 290 1.3× 121 1.0× 76 0.7× 39 0.4× 74 1.6× 45 503
Kun Zhuang China 13 262 1.2× 185 1.5× 51 0.5× 106 1.0× 46 1.0× 28 425
Jian Gong China 12 217 1.0× 120 1.0× 47 0.4× 49 0.5× 30 0.7× 26 436
Minh Nam Nguyen Vietnam 13 258 1.2× 98 0.8× 84 0.8× 42 0.4× 58 1.3× 40 555
Jan Dimberg Sweden 15 167 0.8× 117 0.9× 147 1.4× 91 0.9× 45 1.0× 32 512
Ruiyue Shi China 11 159 0.7× 85 0.7× 64 0.6× 51 0.5× 54 1.2× 40 343

Countries citing papers authored by Dian-xu Feng

Since Specialization
Citations

This map shows the geographic impact of Dian-xu Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian-xu Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian-xu Feng more than expected).

Fields of papers citing papers by Dian-xu Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian-xu Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian-xu Feng. The network helps show where Dian-xu Feng may publish in the future.

Co-authorship network of co-authors of Dian-xu Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Dian-xu Feng. A scholar is included among the top collaborators of Dian-xu Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian-xu Feng. Dian-xu Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tu, Lei, Ya‐Feng Chen, Xinjuan Fan, et al.. (2024). Da-Cheng-Qi decoction improves severe acute pancreatitis capillary leakage syndrome by regulating tight junction-associated proteins. Frontiers in Pharmacology. 15. 1138251–1138251. 4 indexed citations
3.
Li, Jie, Yafeng Chen, Lei Gao, Yijie Li, & Dian-xu Feng. (2023). Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1. Chinese Journal of Integrative Medicine. 30(6). 534–542. 6 indexed citations
4.
Sun, Wenjie, et al.. (2020). Bibliometric analysis of acute pancreatitis in Web of Science database based on CiteSpace software. Medicine. 99(49). e23208–e23208. 24 indexed citations
5.
Sun, Wenjie, Yafeng Chen, Hongchang Li, et al.. (2019). Material basis and molecular mechanisms of Dachengqi decoction in the treatment of acute pancreatitis based on network pharmacology. Biomedicine & Pharmacotherapy. 121. 109656–109656. 31 indexed citations
6.
Sun, Guifang, Hongchang Li, Yueping Zhan, et al.. (2019). SnoN residue (1–366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation. Laboratory Investigation. 99(12). 1861–1873. 6 indexed citations
7.
Wang, Jie, Chao Chen, Yong Zhang, et al.. (2018). ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT. Molecular Medicine Reports. 18(4). 3751–3759. 14 indexed citations
9.
Chen, Yafeng, Hongchang Li, Wenjie Sun, et al.. (2017). Dachengqi Decoction Attenuates Intestinal Vascular Endothelial Injury in Severe Acute Pancreatitis in Vitro and in Vivo. Cellular Physiology and Biochemistry. 44(6). 2395–2406. 25 indexed citations
10.
Li, Hongchang, Ya‐Feng Chen, Fan Yang, et al.. (2017). Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo. Cellular Physiology and Biochemistry. 43(5). 1829–1840. 57 indexed citations
11.
Li, Hongchang, Yafeng Chen, Wen Feng, et al.. (2016). Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway. Gene. 603. 1–8. 35 indexed citations
12.
Wen, Feng, Hongchang Li, Ke Xu, et al.. (2016). SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line. Gene. 587(1). 91–97. 60 indexed citations
13.
Li, Hongchang, Yafeng Chen, Teng Chen, et al.. (2016). Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis. Pancreatology. 16(2). 211–217. 18 indexed citations
14.
Chen, Ya‐Feng, Hongchang Li, Jiyun Tian, et al.. (2015). Cartilage Oligomeric Matrix Protein-Angiopoietin-1 Has a Protective Effect of Vascular Endothelial Barrier in Rat With Acute Necrotizing Pancreatitis. Pancreas. 45(1). 142–147. 4 indexed citations
15.
Chen, Yafeng, Hongchang Li, Cheng Liu, et al.. (2015). Dachengqi Decoction Attenuates Inflammatory Response via Inhibiting HMGB1 Mediated NF-κB and P38 MAPK Signaling Pathways in Severe Acute Pancreatitis. Cellular Physiology and Biochemistry. 37(4). 1379–1389. 32 indexed citations
16.
Wang, Jie, Chao Chen, Shiying Wang, et al.. (2015). Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways. Gastroenterology Research and Practice. 2015. 1–10. 38 indexed citations
17.
Feng, Dian-xu, Wen Peng, Yafeng Chen, et al.. (2012). Down-Regulation of Aquaporin 1 in Rats With Experimental Acute Necrotizing Pancreatitis. Pancreas. 41(7). 1092–1098. 16 indexed citations
18.
Yan, Ronglin, Dian-xu Feng, Ronghua Zhao, et al.. (2011). Loss of imprinting and abnormal expression of the insulin‐like growth factor 2 gene in gastric cancer. Molecular Carcinogenesis. 50(5). 390–396. 18 indexed citations
19.
Feng, Dian-xu. (2010). Developments on the Treatment of Severe Aente Pancreatitis by Western Medicine Combined with TCM. Lishizhen Medicine and Materia Medica Research. 1 indexed citations
20.
Feng, Dian-xu, et al.. (2002). A Prospective Study of Detection of Pancreatic Carcinoma by Combined Plasma K -ras Mutations and Serum CA19-9 Analysis. Pancreas. 25(4). 336–341. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026